एपीए उद्धरण

Vogl, U. M., Andalibi, H., Klaus, A., Vormittag, L., Schima, W., Heinrich, B., . . . Öhler, L. (2019). Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: Does sequence matter? BMC.

शिकागो स्टाइल उद्धरण

Vogl, Ursula M., Haleh Andalibi, Alexander Klaus, Laurenz Vormittag, Wolfgang Schima, Bettina Heinrich, Alice Kafka, Thomas Winkler, और Leopold Öhler. Nab-paclitaxel and Gemcitabine or FOLFIRINOX As First-line Treatment in Patients With Unresectable Adenocarcinoma of the Pancreas: Does Sequence Matter? BMC, 2019.

एमएलए उद्धरण

Vogl, Ursula M., et al. Nab-paclitaxel and Gemcitabine or FOLFIRINOX As First-line Treatment in Patients With Unresectable Adenocarcinoma of the Pancreas: Does Sequence Matter? BMC, 2019.